What is NDC 73473-905?

73473-905 is the product NDC for brivaracetam, Brivaracetam 25 mg/1 tablet, film coated, listed with the FDA by SolarisPharmaCorporation. It has 1 package NDC, shown above in 10- and 11-digit form.

SolarisPharmaCorporation, NDC labeler code 73473. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for brivaracetam?

52 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

brivaracetam NDC 73473-905 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)73473-905Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73473-0905Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73473-905-60	7347309056073473090560	60 TABLET, FILM COATED in 1 BOTTLE (73473-905-60)Marketed from Feb 4, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): brivaracetam
Generic name (nonproprietary): brivaracetam
Active ingredients: Brivaracetam — 25 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: SolarisPharmaCorporationNDC labeler code 73473
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214748
Marketing start: Feb 4, 2026
Listing expires: Dec 31, 2027
DEA schedule: CV
Other FDA classes: Epoxide Hydrolase Inhibitors (Mechanism)
Identifiers: Product ID 73473-905_582096b8-9351-949b-e063-6394a90ad460SPL ID 582096b8-9351-949b-e063-6394a90ad460SPL set ID 49f726ec-e51b-7516-e063-6294a90ae684RxCUI 1739761, 1739768, 1739772, 1739776, 1739780UNII U863JGG2IAUPC 0373473907603, 0373473906606, 0373473905609, 0373473908600

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473473090560 followed by a unit qualifier and the quantity

Package 73473-0905-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 3, 2026.

Indications (excerpt from the label)

Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73473-905

What is NDC 73473-905?: 73473-905 is the product NDC for brivaracetam, Brivaracetam 25 mg/1 tablet, film coated, listed with the FDA by SolarisPharmaCorporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: brivaracetam.
What is the active ingredient?: Brivaracetam.
Who is the labeler?: SolarisPharmaCorporation, NDC labeler code 73473. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for brivaracetam?: 52 other product NDCs are listed under this name. See all brivaracetam NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other brivaracetam NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Brivaracetam	Brivaracetam 10 mg/mL	SolutionOral	Aurobindo Pharma Limited	59651-995	59651-0995-03
Brivaracetam	Brivaracetam 10 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc	76282-822	76282-0822-60
Brivaracetam	Brivaracetam 25 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc	76282-823	76282-0823-60
Brivaracetam	Brivaracetam 50 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc	76282-824	76282-0824-60
Brivaracetam	Brivaracetam 75 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc	76282-825	76282-0825-60
Brivaracetam	Brivaracetam 100 mg/1	Tablet, Film coatedOral	Exelan Pharmaceuticals, Inc	76282-826	76282-0826-60
Brivaracetam	Brivaracetam 10 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-068	84386-0068-60
Brivaracetam	Brivaracetam 25 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-069	84386-0069-60
Brivaracetam	Brivaracetam 75 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	84386-071	84386-0071-60
brivaracetam	Brivaracetam 25 mg/1	Tablet, Film coatedOral	AvKARE	73190-074	73190-0074-60

All 53 brivaracetam NDCs

Other NDCs under ANDA 214748

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214748
Product	Strength	Form · route	Labeler	Product NDC
brivaracetam	Brivaracetam 10 mg/1	Tablet, Film coatedOral	SolarisPharmaCorporation	73473-904
brivaracetam	Brivaracetam 50 mg/1	Tablet, Film coatedOral	SolarisPharmaCorporation	73473-906
brivaracetam	Brivaracetam 75 mg/1	Tablet, Film coatedOral	SolarisPharmaCorporation	73473-907
brivaracetam	Brivaracetam 100 mg/1	Tablet, Film coatedOral	SolarisPharmaCorporation	73473-908